Predicting responses to chemotherapy in the context that matters - the patient.

Publication Type:

Journal Article


Molecular & cellular oncology, Volume 3, Issue 1, p.e1057315 (2016)


Guided by the belief that the most important setting for understanding tumor response to drugs is the human patient, we developed a technology called CIVO. CIVO enables analysis of up to 8 therapies simultaneously in a patient's tumor, without inducing systemic toxicity and while maintaining the integrity of the native tumor microenvironment.